IGF-1 DES is a 67-amino-acid truncated IGF-1 analog created by deletion of the N-terminal tripeptide, which reduces its binding to IGF binding proteins and increases local tissue bioavailability
This knowledge empowers patients to report any changes promptly and participate actively in their treatment plan
This article breaks down the real differences between injectable and sublingual CJC-1295 + Ipamorelin, and explains why the sublingual route has become the preferred option at TruHealth PT
Ford et al ., 1991)
So maybe in some secondary analysis, we'd say, "Well, Nirala would not be cool with that." Maybe we separate those out and see Nirala kosher versus Nirala unkosher stuff
In other words, rather than a substitute for exercise, GLP-1s can take some credit for ushering new runners, like Ford, into the sport to begin with